Drug testing

A new microfluidic liver-on-a-chip platform offers drug developers a stable, scalable and sensitive testing ground for much-needed treatments in fatty liver disease.

A*STAR researchers have devised a method to generate a renewable source of mature human Kupffer cells for liver toxicity bioassays.

A new culturing method mimics the natural forces acting on liver cells, opening new doors in cell culture research